Global Animal Parasiticides Market – North America is expected to account for higher market share of more than 30% driven by large scale industrial animal farming and elevated number of pet population -Market Analysis 2013 – 2019 and Forecast 2019 – 2026

Global Animal Parasiticides Market is expected to reach US$ 13.7 Bn. at a CAGR of 5.4 during the forecast period 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.   The growth is coupled with a rise in the zoonotic diseases prevalence and transmission from pets and farm animals to humans is envisaged to drive the global market. According to the ESCCAP, dogs and cats in Europe are frequently infested with endoparasites, ectoparasites, and other vector-borne parasites. The body sets up guidelines for the prevention, control, and treatment of companion animal parasites, with an aim to protect pet’s health as well as public’s health by plummeting the possible risk of zoonotic parasite transmission. The rising number of companion animals and the preventive measures taken by their owners will serve as a high impact rendering factor for spurring pet parasiticides products demand. Furthermore, the rising focus of animal health companies on developing promising animal parasiticides products will propel business growth over the coming years. North America had the highest market share in 2017. The Global Animal Parasiticides Market is driven by large-scale industrial animal farming and the elevated number of the pet population. Moreover, early adoption tendency for neoteric products results in the rapid realization of sales in the United States. Other factors including growth in a number of farm animals, consequently their consumption and rising rate of pet adoption. Asia Pacific market presents a lucrative opportunity in the expansion of Asia-Pacific industry size due to factors such as rising disposable incomes of pet owners, awareness about animal products and increasing penetration of animal health companies in India and China. Endoparasiticides accounted for the largest Global Animal Parasiticides Market share in 2017 and is estimated to witness significant growth over the forecast period, owing to the elevated use of endoparasiticides in development of new products. Easy to use and effective nature of pour-ons and spot-ons should drive the ectoparasiticides market with CAGR of around 4% during the forecast period, be indebted to the rising popularity and elevated usage of pour-on and spot-on formulations. The objective of the report is to present comprehensive Global Animal Parasiticides Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Animal Parasiticides Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Animal Parasiticides Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Animal Parasiticides Market  North America for Asia Pacific make the report investor’s guide.

Global Animal Parasiticides Market Segmentation:

• Global Animal Parasiticides Market By Product o Ectoparasiticides  Sprays  Dips  Collars  Pour-Ons and Spot-Ons  Ear Tags

o Endoparasiticides  Injectables  Orals  Feed additives o Endectocides

• Global Animal Parasiticides Market By Animal Type

o Farm Animals o Companion Animals The above data will be provided for following regions/countries from 2018-2029 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia • Key players Sanofi Ceva Sante Animale Virbac Vetoquinol S.A Eli Lilly and Company B. Braun Melsungen AG Zoetis, Inc. Olympus Corporation Boston Scientific Corporation FUJIFILM Holdings Corporation INRAD, Inc Medtronic plc Merck and Co., Inc. Hologic, Inc. Bayer AG Boehringer Ingelheim Perrigo Company Plc Vetoquinol S.A. Mauna Kea Technologies Argon Medical Devices, Inc What information is covered in a Report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017

Global Animal Parasiticides Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Animal Parasiticides Market overview 2.1.1. By Products 2.1.2. By Animal Type Chapter 3 Global Animal Parasiticides Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Rising number of companion animals 3.2.1.2. Increasing animal livestock population 3.2.2. Market Restrains 3.2.2.1. Growing preference for vegetarian food and diet 3.3. Market share analysis 3.3.1. By Products 3.3.2. By Animal Type 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Animal Parasiticides Market, By Products 4.1. Key segment trends 4.2. Ectoparasiticides 4.2.1. Market size, by region, 2013 - 2024 4.3. Sprays 4.3.1. Market size, by region, 2019-2026 4.4. Dips 4.4.1. Market size, by region, 2019-2026 4.5. Collars 4.5.1. Market size, by region, 2019-2026 4.6. Pour-Ons and Spot-Ons 4.6.1. Market size, by region, 2019-2026 4.7. Ear Tags 4.7.1. Market size, by region, 2019-2026 4.8. Endoparasiticides 4.8.1. Market size, by region, 2019-2026 4.9. Injectables 4.9.1. Market size, by region, 2019-2026 4.10. Orals 4.10.1. Market size, by region, 2019-2026 4.11. Feed additives 4.11.1. Market size, by region, 2019-2026 4.12. Endectocides 4.12.1. Market size, by region, 2019-2026 4.12.2. Key Trends in Global Animal Parasiticides Market 5. Animal Parasiticides Market, By Animal Type 5.2. Key segment trends 5.3. Farm Animals 5.3.1. Market size, by region, 2013 - 2024 5.4. Companion Animals 5.4.1. Market size, by region, 2019-2026 Chapter 6 Animal Parasiticides Market, By Region 6.1. Key regional trends 6.2. North America 6.2.1. Market size, by country, 2019-2026 6.2.2. Market size, by products, 2019-2026 6.2.3. Market size, by animal type, 2019-2026 6.2.4. U.S. 6.2.4.1. Market size, by products, 2019-2026 6.2.4.2. Market size, by animal type, 2019-2026 6.2.5. Canada 6.2.5.1. Market size, by products, 2019-2026 6.2.5.2. Market size, by animal type, 2019-2026 6.3. Europe 6.3.1. Market size, by country, 2019-2026 6.3.2. Market size, by products, 2019-2026 6.3.3. Market size, by animal type, 2019-2026 6.3.4. Germany 6.3.4.1. Market size, by products, 2019-2026 6.3.4.2. Market size, by animal type, 2019-2026 6.3.5. UK 6.3.5.1. Market size, by products, 2019-2026 6.3.5.2. Market size, by animal type, 2019-2026 6.3.6. France 6.3.6.1. Market size, by products, 2019-2026 6.3.6.2. Market size, by animal type, 2019-2026 6.3.7. Spain 6.3.7.1. Market size, by products, 2019-2026 6.3.7.2. Market size, by animal type, 2019-2026 6.3.8. Italy 6.3.8.1. Market size, by products, 2019-2026 6.3.8.2. Market size, by animal type, 2019-2026 6.4. Asia Pacific 6.4.1. Market size, by country, 2019-2026 6.4.2. Market size, by products, 2019-2026 6.4.3. Market size, by animal type, 2019-2026 6.4.4. India 6.4.4.1. Market size, by products, 2019-2026 6.4.4.2. Market size, by animal type, 2019-2026 6.4.5. China 6.4.5.1. Market size, by products, 2019-2026 6.4.5.2. Market size, by animal type, 2019-2026 6.4.6. Japan 6.4.6.1. Market size, by products, 2019-2026 6.4.6.2. Market size, by animal type, 2019-2026 6.4.7. Australia 6.4.7.1. Market size, by products, 2019-2026 6.4.7.2. Market size, by animal type, 2019-2026 6.5. Latin America 6.5.1. Market size, by country, 2019-2026 6.5.2. Market size, by products, 2019-2026 6.5.3. Market size, by animal type, 2019-2026 6.5.4. Argentina 6.5.4.1. Market size, by products, 2019-2026 6.5.4.2. Market size, by animal type, 2019-2026 6.5.5. Brazil 6.5.5.1. Market size, by products, 2019-2026 6.5.5.2. Market size, by animal type, 2019-2026 6.5.6. Mexico 6.5.6.1. Market size, by products, 2019-2026 6.5.6.2. Market size, by animal type, 2019-2026 6.6. Middle East and Africa 6.6.1. Market size, by country, 2019-2026 6.6.2. Market size, by products, 2019-2026 6.6.3. Market size, by animal type, 2019-2026 6.6.4. South Africa 6.6.4.1. Market size, by products, 2019-2026 6.6.4.2. Market size, by animal type, 2019-2026 6.6.5. Saudi Arabia 6.6.5.1. Market size, by products, 2019-2026 6.6.5.2. Market size, by animal type, 2019-2026 Chapter 6 Consolidations 7.1. Mergers and Acquisitions 7.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 7.3. Patent Analysis 7.4. Key players 7.4.1. Sanofi 7.4.1.1. Company overview 7.4.1.2. Key financials 7.4.1.3. Product landscape 7.4.1.4. Strategic initiatives 7.4.1.5. SWOT analysis 7.4.2. Ceva Sante Animale 7.4.2.1. Company overview 7.4.2.2. Key financials 7.4.2.3. Product landscape 7.4.2.4. Strategic initiatives 7.4.2.5. SWOT analysis 7.4.3. Virbac 7.4.3.1. Company overview 7.4.3.2. Key financials 7.4.3.3. Product landscape 7.4.3.4. Strategic initiatives 7.4.3.5. SWOT analysis 7.4.4. Vetoquinol S.A. 7.4.4.1. Company overview 7.4.4.2. Key financials 7.4.4.3. Product landscape 7.4.4.4. Strategic initiatives 7.4.4.5. SWOT analysis 7.4.5. Eli Lilly and Company 7.4.5.1. Company overview 7.4.5.2. Key financials 7.4.5.3. Product landscape 7.4.5.4. Strategic initiatives 7.4.5.5. SWOT analysis 7.4.6. B. Braun Melsungen AG 7.4.6.1. Company overview 7.4.6.2. Key financials 7.4.6.3. Product landscape 7.4.6.4. Strategic initiatives 7.4.6.5. SWOT analysis 7.4.7. Zoetis, Inc. 7.4.7.1. Company overview 7.4.7.2. Key financials 7.4.7.3. Product landscape 7.4.7.4. Strategic initiatives 7.4.7.5. SWOT analysis 7.4.8. Olympus Corporation 7.4.8.1. Company overview 7.4.8.2. Key financials 7.4.8.3. Product landscape 7.4.8.4. Strategic initiatives 7.4.8.5. SWOT analysis 7.4.9. Boston Scientific Corporation 7.4.9.1. Company overview 7.4.9.2. Key financials 7.4.9.3. Product landscape 7.4.9.4. Strategic initiatives 7.4.9.5. SWOT analysis 7.4.10. FUJIFILM Holdings Corporation 7.4.10.1. Company overview 7.4.10.2. Key financials 7.4.10.3. Product landscape 7.4.10.4. Strategic initiatives 7.4.10.5. SWOT analysis 7.4.11. INRAD, Inc. 7.4.11.1. Company overview 7.4.11.2. Key financials 7.4.11.3. Product landscape 7.4.11.4. Strategic initiatives 7.4.11.5. SWOT analysis 7.4.12. Medtronic plc 7.4.12.1. Company overview 7.4.12.2. Key financials 7.4.12.3. Product landscape 7.4.12.4. Strategic initiatives 7.4.12.5. SWOT analysis 7.4.13. Merck and Co., Inc. 7.4.13.1. Company overview 7.4.13.2. Key financials 7.4.13.3. Product landscape 7.4.13.4. Strategic initiatives 7.4.13.5. SWOT analysis 7.4.14. Hologic, Inc. 7.4.14.1. Company overview 7.4.14.2. Key financials 7.4.14.3. Product landscape 7.4.14.4. Strategic initiatives 7.4.14.5. SWOT analysis 7.4.15. Bayer AG 7.4.15.1. Company overview 7.4.15.2. Key financials 7.4.15.3. Product landscape 7.4.15.4. Strategic initiatives 7.4.15.5. SWOT analysis 7.4.16. Boehringer Ingelheim 7.4.16.1. Company overview 7.4.16.2. Key financials 7.4.16.3. Product landscape 7.4.16.4. Strategic initiatives 7.4.16.5. SWOT analysis 7.4.17. Perrigo Company Plc 7.4.17.1. Company overview 7.4.17.2. Key financials 7.4.17.3. Product landscape 7.4.17.4. Strategic initiatives 7.4.17.5. SWOT analysis 7.4.18. Vetoquinol S.A. 7.4.18.1. Company overview 7.4.18.2. Key financials 7.4.18.3. Product landscape 7.4.18.4. Strategic initiatives 7.4.18.5. SWOT analysis 7.4.19. Mauna Kea Technologies 7.4.19.1. Company overview 7.4.19.2. Key financials 7.4.19.3. Product landscape 7.4.19.4. Strategic initiatives 7.4.19.5. SWOT analysis 7.4.20. Argon Medical Devices, Inc

About This Report

Report ID 11062
Category Healthcare
Published Date oct 2019
Updated Date Dec 2020
Contact Us